BSE filing, NSE: JYOTHYLAB. Summary written from the filing by ALFA Finder's alert engine.
Jyothy Labs Ltd: key numbers
- Share price
- ₹183.00
- Market cap
- ₹6,720 Cr
- Revenue (annual)
- ₹2,944 Cr
- Net profit (annual)
- ₹333.2 Cr
- P/E (TTM)
- 23.7×Sector 40.4×
- Promoter holding
- 62.89%+0.00% QoQ
- FII holding
- 14.48%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Jyothy Labs Ltd
All →Jyothy Labs Investor Presentation: Key Takeaways
Q2 FY27 revenue rose 3.3% to ₹760 Cr, but operating EBITDA margin fell to 2.5% and PAT dropped 87.9% to ₹10.6 Cr on raw-material and packaging inflation.
Jyothy Labs Q2 FY27 Results: Net Profit ₹10.6 Cr, Down 87.9% YoY
Jyothy Labs Ltd reported revenue from operations of ₹760 Cr (+3.2% YoY) and net profit of ₹10.6 Cr (-87.9% YoY) for Q2 FY27.
- Key figure
- Net profit ₹10.6 Cr · -87.9% YoY
Jyothy Labs Board Meeting Date
Jyothy Labs intimated that its board meets on November 4, 2026 to consider a proposal for buyback of fully paid-up equity shares. Trading window stays closed until 48 hours after the outcome is disclosed.
Jyothy Labs Promoter Buying (Off-Market)
Jyothy Labs filed its quarterly shareholding pattern. It disclosed an inter-se gift of shares within the promoter group, adding family trusts to the promoter group category.
Jyothy Labs Board Meeting Date
Jyothy Labs has scheduled its Board of Directors meeting for November 4, 2026. The agenda includes approval of un-audited financial results for Q1 and H1 2026.
Jyothy Labs Employee Stock Options
Jyothy Labs allotted 21,009 equity shares upon exercise of Restricted Stock Units. This increases the company's total paid-up share capital.
Other results update announcements
All →Steel Exchange India Results Update
Steel Exchange India Ltd reported a nine-fold surge in Q2 FY27 PAT to ₹18 Crore. Revenue rose 46% to ₹343 Crore alongside a ₹102 Crore debt reduction.
- quarterly production
- 69617.42 MT
Alembic Pharmaceuticals Results Update
Alembic Pharmaceuticals reported Q2 FY27 revenue growth of 36% to ₹2,603 Crore. Net profit surged 81% to ₹335 Crore, driven by exceptional US business performance.
- Value
- ₹2,603 Cr
SJS Enterprises Results Update
S.J.S. Enterprises reported record quarterly revenue of Rs. 282.73 Crore, up 16.9% YoY. Net profit for Q2FY27 rose 34.8% YoY to Rs. 58.33 Crore.
- Value
- ₹282.7 Cr
Meghmani Organics Results Update
MOL reported Q2 FY27 revenue of ₹658.2 crore, up 18% YoY, with net profit of ₹45.3 crore. EBITDA margin eased to 10.8% on elevated input costs.
GPT Infraprojects Results Update
GPT Infraprojects reported Q2 FY27 revenue of ₹291.4 crore and PAT of ₹18.3 crore. Order inflow was ₹1,491 crore; interim dividend of ₹1 declared.
- Order book
- ₹5,373 Cr
Indo Count Industries Results Update
Indo Count reported record Q2 FY27 income of ₹1,699 Cr and PAT of ₹132 Cr. H1 EBITDA grew 73% YoY to ₹420 Cr.